The commensal bacterium Faecalibacterium prausnitzii plays a key role in IBD pathogenesis, and Butyrate mediates the anti-inflammatory effects of Faecalibacterium prausnitzii in intestinal epithelial cells through Dact3 [44]. Here, DACT3 is linked to inflammatory bowel disease.